Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Venclexta® (venetoclax) – Expanded indication
May 16, 2019 - Roche announced the FDA approval of Venclexta (venetoclax), for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
